Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria.

Palliative and supportive care end of life multidisciplinary team psycho-oncology

Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
14 Oct 2024
Historique:
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: aheadofprint

Résumé

We conducted an online survey to investigate oncologists' clinical practices and views on palliative care at the end of life in the Italian region of Liguria. The survey included 29 items divided into three sections: participant characteristics (n=6), hospital resources and practices (n=11), participant practices and views (n=12). Twenty-one of the 41 medical oncologists invited completed the survey (51%). Although almost all reported the presence of palliative medicine physicians at their hospitals (90%), nearly half (48%) stated that palliative medicine physicians were not responsible for managing cancer patients at end of life, and 21% reported routine participation of palliative medicine physicians in multidisciplinary meetings. Thirty-eight percent of the respondents stated they never consulted psychologists regarding end of life patient care, and 43% reported they rarely did. Notably, a substantial proportion of participants stated that they administered active treatments to patients with six months life expectancy. Regarding integration between oncology and palliative medicine, an equal proportion felt it had been fully (48%) or partially achieved (48%) at their hospitals. Participants seemed fairly satisfied with the level of integration between oncology and palliative medicine at their hospitals, which contrasts with other findings regarding, for instance, the scant participation of palliative medicine physicians in multidisciplinary meetings. Exploring the impact of the novel regional clinical healthcare pathway for palliative care on practices at hospitals in Liguria will be crucial to ensure that cancer patients at end of life receive quality care.

Identifiants

pubmed: 39402743
doi: 10.1177/03008916241287616
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3008916241287616

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Irene Giannubilo (I)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.

Linda Battistuzzi (L)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Tommaso Ruelle (T)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.

Francesca Benedetta Poggio (FB)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Giulia Buzzatti (G)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Alessia D'Alonzo (A)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Federica Della Rovere (F)

SSD Cure Palliative ed Hospice, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Chiara Molinelli (C)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.

Maria Grazia Razeti (MG)

Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Simone Nardin (S)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.

Luca Arecco (L)

Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Marta Perachino (M)

Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Diletta Favero (D)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.

Roberto Borea (R)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.

Paolo Pronzato (P)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Lucia Del Mastro (L)

Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Stefania Vecchio (S)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Claudia Bighin (C)

U.O. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Classifications MeSH